Pennino Corporation TECHNOLOGY TO IMPROVE LIFE

Size: px
Start display at page:

Download "Pennino Corporation TECHNOLOGY TO IMPROVE LIFE"

Transcription

1 Pennino Corporation TECHNOLOGY TO IMPROVE LIFE

2 Agenda The Opportunity Highlights Corporate Profile NYU Relationship Obesity and Diabetes Graphics and Facts Next Stage of Development Efficacy and Safety Foreign Governmental Approval Exit / Liquidity Strategies 2

3 The Opportunity A partnership between Pennino Corp. and New York University (NYU) is developing a drug that decreases body fat, increases lean body mass and lowers cholesterol simultaneously Obesity and related diseases like Type 2 Diabetes, Heart Disease, Stroke and Cancer may be prevented or treated with this technology saving millions of lives and billions in healthcare costs Test data indicates fat weight-loss is 5 times greater and 5 times faster than any drug available or in trials today The discovery may be the secret to how the body converts energy from fat to muscle May open a new area of science and could be a Nobel Prize winning breakthrough 3

4 Highlights of Technology and Company Reduces Obesity/Body Fat - Obesity (Adult and Childhood) is the world s number one health epidemic and is directly tied to Cancer, Diabetes, Heart Disease and Stroke Reduces Type 2 Diabetes - Diabetes is directly correlated to obesity and is a leading health expenditure and the #6 cause of death Reduces Cholesterol Our technology has shown to reduce cholesterol better than any existing drug. Cholesterol is a leading heart disease indicator and cholesterol drugs sell over $30Billion annually Increases Lean Body Mass In addition to reducing body fat we are simultaneously increasing lean body mass - a medical miracle World Class University Partner By partnering with NYU, we are working with the top scientists in the world and with cutting-edge equipment IPO/Acquisition Opportunity A drug that can treat ANY of the above diseases is worth billions. We may treat ALL of them and become the biggest drug in history 4

5 Corporate Profile Incorporated in Delaware Filing in February 2007 Company based in New York, NY Joe Pennino is CEO and Chairman The only asset in the Company is the license from NYU (New York University) 5

6 Joe Pennino CEO and Founder Joe Pennino is an experienced CEO and Wall Street veteran who started his career as a CPA with PriceWaterhouseCoopers. He then worked in the institutional capital markets and investment banking at HSBC, Royal Bank of Scotland and Standard Bank and was based out of New York and London. Mr. Pennino is also an investor in technology companies and has been an executive with many early stage technology companies. Mr. Pennino believes the power of science is critical for the health of the global economy and to improve life. Mr. Pennino holds a Masters in Business Administration from Columbia University and has completed coursework at Columbia University Law School. He holds a degree in Accounting and Finance from University of Illinois and has also completed Executive Education at MIT. 6

7 NYU Relationship Pennino Corp. has exclusive, worldwide license for compound(s) discovered at NYU for various disease indications including Obesity, Type 2 Diabetes, and Cholesterol NYU will receive payments for research and royalties on future sales for the life of patents related to this discovery NYU Scientific Team has two senior PhD's planning and directing all testing to obtain the active molecule(s) NYU also has a dedicated technical staff to execute lab work All work is carried out at NYU facilities under strict security and regulatory guidelines 7

8 Obesity in America

9 Obesity Facts The US is currently spending $150 billion (10% of all medical spending) annually on Obesity and related complications, double the cost in 1998, and more than every Cancer put together By 2018, 40% of Americans will be Obese and spending will rise to $344 billion annually By 2030, 86% of Americans will be Overweight and 51% will be Obese Healthcare costs related to Obesity are expect to double each decade and reach $957 billion annually by 2030, or 1 out of every 6 healthcare dollars spent in the US Obesity is attributed to causing the following percentage of cancers: 49% of endometrial, 35% of esophageal, 28% of pancreatic, 24% of kidney, 21% of gallbladder,17% of breast, and 9% of Colon cancer Worldwide, 1.5 billion people will be overweight or obese by

10 Obesity is a Global Problem 10

11 Global Obesity Map 11

12 Childhood Obesity Facts Michelle Obama has launched a new initiative from the White House against Childhood Obesity working with the Human Health Services Department, the Surgeon General and the FDA 33% of all children are Overweight or Obese today 20% of children ages 6 to 11 are Obese today 18% of children ages 12 to 19 are Obese today 33% of children eventually will suffer diabetes and in Latino and African American communities the number will be 50% 20% of children ages 12 to 19 have High Cholesterol 12

13 Global Childhood Obesity is Exploding 13

14 Diabetes Facts The number of Americans with Diabetes is expected to double in the next 25 years from the current 23.7 million to 44.1 million by 2034 Aging Baby Boomers will have a huge effect on Diabetes and Medicare- currently 8.2million with Diabetes are covered by Medicare costing $45 billion annually and by million with Diabetes will be covered by Medicare costing $171 billion annually 57 million Americans are pre-diabetic today 1.6 million new cases of Diabetes are diagnosed each year Diabetes is associated with Heart Disease, Stroke, High Blood Pressure, Blindness, Nervous System Disease, Kidney Disease, and often requires lower limb amputation 14

15 Diabetes in the US 15

16 Global Diabetes Map

17 Correlation of Adult Obesity & Diabetes 17

18 Next Stage of Development Money raised today will complete the isolation of the active molecule(s) NYU has experts in isolating and identifying key molecules from plants Discovery of the molecule is a mathematical process-of-elimination: Assuming there are 500 chemicals in the extract, the scientists will quickly identify and eliminate the vast majority of known chemicals and focus on the remainder until we find the key compound(s) A combination of high tech/expensive equipment, cell culture, and animal studies are being used Once molecule(s) is/are identified, patents will be filed to protect our very valuable intellectual property NYU will likely publish the discovery in medical journals where it should become a global headline story 18

19 Efficacy and Safety The results achieved so far are: significantly greater than those from competitors beyond FDA minimum requirements (5% reduction in body fat) Our test demonstrated close to a 25% reduction in body fat, or 5x greater than necessary Doctors have stated they need to see a 10-15% fat reduction to be considered a useful drug The plant is organic and has been eaten by humans before without negative side effects giving us comfort that this drug is safe. Our own NYU PhD. ate the plant extract himself with: no noticeable negative side effects positive effects of fat reduction, lean body maintenance and lowered cholesterol 19

20 Foreign Government Drug Approval Obesity, Type 2 Diabetes, Cancer, Heart Disease, high Cholesterol, etc are global health problems and Pennino Corp. will seek approval for drug sales in many countries The FDA is often considered the most difficult agency and other agencies move faster with fewer restrictions It is therefore likely that we will be able to sell the drug internationally before we can sell the drug in the US Pennino Corp. will hire the appropriate consultants and work with foreign agencies to meet the requirements to sell our drug in their respective countries Pennino Corp. sees revenue opportunities globally since most people in the world suffer from the diseases we hope to solve 20

21 Exit / Liquidity Strategies IPO There are 2 possible exit strategies: IPO or Acquisition An IPO is most likely to occur around Phase 2 when the valuation has increased within the investing community Proceeds from IPO s are used to continue clinical trials and offers liquidity to investors An IPO for a technology like ours is certain to gather a tremendous amount of interest given the sheer size of the healthcare problems we are addressing Currently we are reviewing the idea of IPO s in New York, London, Dubai and Shanghai 21

22 Exit / Liquidity Strategies - Acquisition An acquisition is the more common route for a bio company and it can happen at any time We would not be surprised to have significant offers even after the patents are filed because Big Pharma is desperate for Patent Pipeline as their important patents are expiring. There is no shortage of both big companies and smaller companies being acquired in recent days: Pfizer acquired Wyeth for $61billion Merck acquired Schering-Plough for $41billion Even smaller, developmental companies get acquired at huge valuations: Cougar Biotechnology was bought by Johnson & Johnson for $1 billion Sirtris was acquired by GlaxoSmithKline for $720 million (FYI, neither of the developmental companies had products approved by the FDA and had drugs for much smaller markets than our target markets. 22

23 Thank You Thank you for reviewing this introductory presentation For more details on the history, data, and future plans, please request our Confidentiality Agreement and we will schedule a meeting with you. We look forward to working with you Joe Pennino CEO and Founder Pennino Corporation

Why Are Drugs So Expensive? Learning About the Drug Development Process

Why Are Drugs So Expensive? Learning About the Drug Development Process Why Are Drugs So Expensive? Page 1 of 92 Why Are Drugs So Expensive? Learning About the Drug Development Process written by: Ann Newman Seventh Street Development Group This product is for your Personal

More information

Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014

Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014 Oramed Pharmaceuticals, Inc. Initiating Report Breakthrough oral drug delivery technology for diabetes, drugs and vaccines November 5, 2014 Key data Sector Rating Biotechnology BUY Target Price $45.00

More information

Nutrition Club Opportunity Meeting

Nutrition Club Opportunity Meeting Nutrition Club Opportunity Meeting Established in 1980 Founder Mark Hughes In business 32 years 60 million clients 80+ countries $4.2 Billion in 2010 Industry leader NYSE Listed 2 CEO - Herbalife International

More information

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE

Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes NATIONAL DIABETES INFORMATION CLEARINGHOUSE NATIONAL DIABETES INFORMATION CLEARINGHOUSE Am I at Risk for type 2 Diabetes? Taking Steps to Lower the Risk of Getting Diabetes U.S. Department of Health and Human Services National Institutes of Health

More information

PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison

PATHWAYS TO TYPE 2 DIABETES. Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison PATHWAYS TO TYPE 2 DIABETES Vera Tsenkova, PhD Assistant Scientist Institute on Aging University of Wisconsin-Madison Overview Diabetes 101 How does diabetes work Types of diabetes Diabetes in numbers

More information

A Start-up company to start your career. Professional Development Seminar March 6, 2013

A Start-up company to start your career. Professional Development Seminar March 6, 2013 A Start-up company to start your career Professional Development Seminar March 6, 2013 What is a start-up company? Small, just started Typically 1-5 years old Often no products, no sales Developing something

More information

Phenomenome Discoveries. Cutting Edge Disease Prevention Research 1

Phenomenome Discoveries. Cutting Edge Disease Prevention Research 1 Cutting Edge Disease Prevention Research 1 Phenomenome Discoveries Inc. Phenomenome Discoveries Inc (PDI) is a life science company focused on the discovery and development of simple blood chemistry tests

More information

Alzheimer s Impact on the American People and the Economy

Alzheimer s Impact on the American People and the Economy www.alz.org Public Policy Office 202 393 7737 p 1212 New York Avenue, NW 866 865 0270 f Suite 800 Washington, DC 20005-6105 Testimony of Harry Johns, President and CEO of the Alzheimer s Association Fiscal

More information

A Tefen Series: Operational Excellence in the Life Sciences Part 1: State of the Industry

A Tefen Series: Operational Excellence in the Life Sciences Part 1: State of the Industry A Tefen Series: Operational Excellence in the Life Sciences Part 1: State of the Industry Executive Summary The life sciences industry is under pressure from the decline in the discovery of block-buster

More information

The Trim Slim Shape Program Test Market Results

The Trim Slim Shape Program Test Market Results The Trim Slim Shape Program Test Market Results 1 The state of American Health (why we launched the TSS Program) 2 U.S. Leading in Health Spending, but not leading in health? America is ranked 37 th in

More information

Pediatric Metabolic Syndrome

Pediatric Metabolic Syndrome University of Michigan Hospitals and Health Centers Pediatric Metabolic Syndrome A growing epidemic Shannon Russell Dietetic Intern June 2012 Overview Causes Risk Factors Signs and Symptoms Identification/Diagnosis

More information

CHAPTER TWO. The Cost of Obesity

CHAPTER TWO. The Cost of Obesity CHAPTER TWO The Cost of Obesity T he obesity epidemic accounts for a growing share of the nation s health expenditures. U.S. health care costs due to obesity were estimated at $74.2 billion in 1998, or

More information

Alzheimer s disease and diabetes

Alzheimer s disease and diabetes 1007029 CM1053CS Alzheimer s disease and diabetes Nearly 21 million Americans in the United States have diabetes, a disease that makes the body less able to convert sugar to energy. More than 6 million

More information

OCAN Comments Suggested Amendments to SFC Chronic Care Working Group Policy Options Paper

OCAN Comments Suggested Amendments to SFC Chronic Care Working Group Policy Options Paper OCAN Comments Suggested Amendments to SFC Chronic Care Working Group Policy Options Paper The Obesity Care Advocacy Network (OCAN) is pleased to provide the following comments in response to the Senate

More information

The Global Biotech Industry: Challenges & Opportunities Michael S. Rosen Rosen Bioscience Strategies

The Global Biotech Industry: Challenges & Opportunities Michael S. Rosen Rosen Bioscience Strategies The Global Biotech Industry: Challenges & Opportunities Michael S. Rosen Rosen Bioscience Strategies Greetings from Chicago! Beaches Yes! Pharma Beginnings! Bogota 1974 Selling Drugs in Colombia Global

More information

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum

Open Innovation: An Imperative for the Pharmaceutical Industry. Berkeley Innovation Forum Open Innovation: An Imperative for the Pharmaceutical Industry Berkeley Innovation Forum October 28-29, 2010 Minneapolis, MN Ted Torphy, Ph.D. Vice President & Head External Innovation Research Capabilities

More information

Projects 12448, Outlook On Biotechnology: Industry Leaders Convention Attendees General Public

Projects 12448, Outlook On Biotechnology: Industry Leaders Convention Attendees General Public Projects 12448, 12458 Outlook On Biotechnology: Industry Leaders Convention Attendees General Public Methodology On behalf of the Biotechnology Industry Organization (BIO), Public Opinion Strategies and

More information

A leading developer of placenta-based cell therapy products October 1, 2014

A leading developer of placenta-based cell therapy products October 1, 2014 Pluristem Therapeutics, Inc. Initiating Report A leading developer of placenta-based cell therapy products October 1, 2014 Key data Sector Rating Biotechnology BUY Target Price $21.00 Current Market Price

More information

Ten Billion Eggs for Mental Health

Ten Billion Eggs for Mental Health Ten Billion Eggs for Mental Health United Paragon Associates Inc April 2013 United Paragon Associates A private Canadian biotech company Discovered a novel potential treatment for MDD, Rellidep TM Completed

More information

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy

Richard T. Clark Chief Executive Officer and President. Executing on Our Strategy Richard T. Clark Chief Executive Officer and President Executing on Our Strategy Merck s Plan to Win: Preparing for Our Future Success BECOME THE MOST TRUSTED INDUSTRY LEADER IN DELIVERING VALUE TO CUSTOMERS

More information

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat?

Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat? Diabetes 101: A Brief Overview of Diabetes and the American Diabetes Association What Happens When We Eat? After eating, most food is turned into glucose, the body s main source of energy. 1 Normal Blood

More information

CE University, Inc. Business Plan Lacture 11B.1. Executive Summary

CE University, Inc. Business Plan Lacture 11B.1. Executive Summary CE University, Inc. Business Plan Lacture 11B.1 The Company Executive Summary CE University, Inc. ( CEU ) is a learning management system company. It is early stage venture that creates and sells online

More information

The Burden Of Diabetes And The Promise Of Biomedical Research

The Burden Of Diabetes And The Promise Of Biomedical Research The Burden Of Diabetes And The Promise Of Biomedical Research Presented by John Anderson, MD Incoming Chair, ADA s National Advocacy Committee; Frist Clinic, Nashville, TN Type 1 Diabetes Usually diagnosed

More information

September 29, About BIO

September 29, About BIO The Comments of the Biotechnology Industry Organization on the Discussion Paper on Compulsory Licenses Published by the Department of Industrial Policy and Promotion within India's Ministry of Commerce

More information

BROUGHT TO YOU BY. Diabetes

BROUGHT TO YOU BY. Diabetes BROUGHT TO YOU BY Diabetes Inside This Issue: You Can t Eat Sugar and Other Diabetes Myths How to Prevent Diabetes When You re at High Risk Could Your Child Have Diabetes? Should You Be Tested for Diabetes?

More information

Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures

Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures Best Practices for Launching Tech Ventures and Leveraging the University Mission Accelerating New Ventures 2011 The University of Texas at Austin IC2 Institute 1 Overview Review of Traditional Innovation

More information

1in3 WHAT WE DO. Our vision is to bring forward the day when all cancers are cured.

1in3 WHAT WE DO. Our vision is to bring forward the day when all cancers are cured. cruk.org WHAT WE DO Our vision is to bring forward the day when all cancers are cured. Thousands of people are alive today thanks to research. Animal studies have played an important part in this progress.

More information

Diabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council

Diabetes 101. Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council Diabetes 101 Francisco J. Prieto, M.D. American Diabetes Association National Advocacy Committee Latino Diabetes Action Council www.diabetes.org 1-800-DIABETES www.diabetes.org 1-800-DIABETES Age-Adjusted

More information

Cover Story, BusinessWeek

Cover Story, BusinessWeek 1 Do Cholesterol Drugs Do Any Good? Research suggests that, except among high-risk heart patients, the benefits of statins such as Lipitor are overstated January 28, 2008 Cover Story, BusinessWeek by John

More information

Mineral rights ownership what is it and why is it so unique in the USA?

Mineral rights ownership what is it and why is it so unique in the USA? Mineral rights ownership what is it and why is it so unique in the USA? Introduction This document is designed to explain the concept of mineral rights ownership, and how such ownership differs between

More information

CAN DIABTES BE PREVENTED OR REVERSED?

CAN DIABTES BE PREVENTED OR REVERSED? Knowledge is power if we use it to invest in our health and future. CAN DIABTES BE PREVENTED OR REVERSED? Old saying: An ounce of prevention is worth a pound of cure Did you know that over one-third of

More information

Insulin Resistance and Pre-diabetes

Insulin Resistance and Pre-diabetes 1 of 6 11/17/2009 9:38 PM Insulin Resistance and Pre-diabetes What is insulin resistance? What causes insulin resistance? Metabolic Syndrome What is pre-diabetes? What are the symptoms of insulin resistance

More information

2019 Healthcare That Works for All

2019 Healthcare That Works for All 2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To

More information

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact

Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact Task Force for the National Conference on Diabetes: The Task Force is comprised of Taking Control of

More information

BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY:

BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY: BIOPHARMACEUTICAL INDUSTRY IMPACT REPORT: Florida PRESENTED BY: About the report About PhRMA The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country s leading innovative

More information

Obesity. Window on America Center Kirovohrad Oblast Research Library Named After Chizhevsky

Obesity. Window on America Center Kirovohrad Oblast Research Library Named After Chizhevsky Obesity Window on America Center Kirovohrad Oblast Research Library Named After Chizhevsky Karin N. Jones Community Development Volunteer, Peace Corps Ukraine Introduction For thousands of years Obesity

More information

Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease

Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease Antipsychotic Medications and the Risk of Diabetes and Cardiovascular Disease Patient Tool #1 Understanding Diabetes and Psychiatric Illness: A Guide for Individuals, Families, and Caregivers Type 2 Diabetes,

More information

Diabetes and Heart Disease

Diabetes and Heart Disease Diabetes and Heart Disease Diabetes and Heart Disease According to the American Heart Association, diabetes is one of the six major risk factors of cardiovascular disease. Affecting more than 7% of the

More information

Nonalcoholic Steatohepatitis

Nonalcoholic Steatohepatitis Nonalcoholic Steatohepatitis National Digestive Diseases Information Clearinghouse National Institute of Diabetes and Digestive and Kidney Diseases NATIONAL INSTITUTES OF HEALTH Nonalcoholic steatohepatitis

More information

OPEN INNOVATION STRATEGIES IN THE HEALTHCARE INDUSTRY

OPEN INNOVATION STRATEGIES IN THE HEALTHCARE INDUSTRY NINESIGMA WHITE PAPER OPEN INNOVATION STRATEGIES IN THE HEALTHCARE INDUSTRY How six leading healthcare companies are leveraging Open Innovation to achieve their innovation goals By: Stephen Clulow, Director

More information

The Promise and Challenge of Adaptive Design in Oncology Trials

The Promise and Challenge of Adaptive Design in Oncology Trials THE POWER OFx Experts. Experience. Execution. The Promise and Challenge of Adaptive Design in Oncology Trials Clinical oncology trials are more complex and time consuming than those in any other therapeutic

More information

ECONOMIC COSTS OF PHYSICAL INACTIVITY

ECONOMIC COSTS OF PHYSICAL INACTIVITY ECONOMIC COSTS OF PHYSICAL INACTIVITY This fact sheet highlights the prevalence and health-consequences of physical inactivity and summarises some of the key facts and figures on the economic costs of

More information

All About Body Mass Index (BMI)

All About Body Mass Index (BMI) All About Body Mass Index for Adults What is BMI? Body Mass Index is a number calculated from a person's weight and height. BMI is a fairly reliable indicator of body fat for most people. BMI does not

More information

Type 1 Diabetes ( Juvenile Diabetes)

Type 1 Diabetes ( Juvenile Diabetes) Type 1 Diabetes W ( Juvenile Diabetes) hat is Type 1 Diabetes? Type 1 diabetes, also known as juvenile-onset diabetes, is one of the three main forms of diabetes affecting millions of people worldwide.

More information

Korea: Understanding Local Markets To Build R&D

Korea: Understanding Local Markets To Build R&D CLINICAL CASE STUDY SERIES Korea: Understanding Local Markets To Build R&D Concerned about the rising burden of cancer due to the aging of its population, in 1989 the Ministry of Health & Welfare in Korea

More information

Testimony of Timothy Coetzee, Ph.D. Representative of a Patient Advocacy Organization President, Fast Forward LLC

Testimony of Timothy Coetzee, Ph.D. Representative of a Patient Advocacy Organization President, Fast Forward LLC Testimony of Timothy Coetzee, Ph.D. Representative of a Patient Advocacy Organization President, Fast Forward LLC Committee on Oversight and Government Reform Domestic Policy Subcommittee U.S. House of

More information

Stem Cell & Regenerative Medicine Research: A Canadian Science & An Innovation Winner

Stem Cell & Regenerative Medicine Research: A Canadian Science & An Innovation Winner Stem Cell & Regenerative Medicine Research: A Canadian Science & An Innovation Winner Author: Dr. Michael Rudnicki, OC, FRSC Scientific Director & CEO, Stem Cell Network Director, Sprott Centre for Stem

More information

Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements

Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements Raising Capital for Life Sciences Companies US IPOs, Mezzanine Rounds, Strategic Partnerships and License Agreements November 2015 Presented by: Stephen Thau 2 BIOTECH IPOS ARE HOT! The Biggest Biotech

More information

The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases. Scott Johnson CEO, President and Founder

The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases. Scott Johnson CEO, President and Founder The Myelin Repair Foundation: Accelerating New Treatments for Multiple Sclerosis and All Diseases Scott Johnson CEO, President and Founder Introduction Broken system of medical research No fault, system

More information

Trends in Innovation in Middle Income Countries: The Case of Biotechnology

Trends in Innovation in Middle Income Countries: The Case of Biotechnology Trends in Innovation in Middle Income Countries: The Case of Biotechnology Joseph Damond, Senior Vice President, International Affairs, Biotechnology Industry Organization INNOVATION AND ACCESS TO MEDICAL

More information

TOP 10 TRENDS IN HEALTHCARE, MEDICAL. HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer

TOP 10 TRENDS IN HEALTHCARE, MEDICAL. HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer TOP 10 TRENDS IN HEALTHCARE, MEDICAL AND PHARMACEUTICAL INDUSTRY HJ ABDUL AZIZ ABDUL RAHMAN Chief Executive Officer KPJSeremban Specialist Hospital KPJ SEREMBAN SPECIALIST HOSPITAL Presented by : Hj Abd

More information

A GENERAL DYNAMICS COMPANY

A GENERAL DYNAMICS COMPANY A GENERAL DYNAMICS COMPANY Forget your credit score and your PIN for now. The numbers that can really determine your future are found in some simple lab results. Cholesterol. Blood pressure. Blood glucose.

More information

the solution. I think too much of the health care issues we re faced with as opposed to the problem.

the solution. I think too much of the health care issues we re faced with as opposed to the problem. Introduction: Hi I m Sherrie Bossing and I manage Lilly s corporate brand and volunteer strategy worldwide. I m joined today with Dr. Jack Harris who is the Vice President responsible for US Medical Division,

More information

When treating a disease is bad business: orphan and neglected diseases

When treating a disease is bad business: orphan and neglected diseases When treating a disease is bad business: orphan and neglected diseases Rocío Acuña Hidalgo Introduction Over the past decades, the development of thousands of new drugs to treat diseases has improved the

More information

Merck Strategy. Richard T. Clark Chief Executive Officer and President

Merck Strategy. Richard T. Clark Chief Executive Officer and President Merck Strategy Richard T. Clark Chief Executive Officer and President The Global Health Care Market is Challenging but Creates Great Opportunity for Merck Challenges Declining success rates in new drug

More information

SCRIPT NUMBER 93 HIGH CHOLESTEROL (ONE SPEAKER)

SCRIPT NUMBER 93 HIGH CHOLESTEROL (ONE SPEAKER) SCRIPT NUMBER 93 HIGH CHOLESTEROL (ONE SPEAKER) PROGRAM NAME: HEALTH NUGGETS PROGRAM TITLE: HIGH CHOLESTEROL PROGRAM NUMBER: 93 SUBJECT: SOURCES, COMPLICATIONS, TREATMENT AND PREVENTION OF HIGH CHOLESTEROL

More information

Is Insulin Effecting Your Weight Loss and Your Health?

Is Insulin Effecting Your Weight Loss and Your Health? Is Insulin Effecting Your Weight Loss and Your Health? Teressa Alexander, M.D., FACOG Women s Healthcare Associates www.rushcopley.com/whca 630-978-6886 Obesity is Epidemic in the US 2/3rds of U.S. adults

More information

Statistics of Type 2 Diabetes

Statistics of Type 2 Diabetes Statistics of Type 2 Diabetes Of the 17 million Americans with diabetes, 90 percent to 95 percent have type 2 diabetes. Of these, half are unaware they have the disease. People with type 2 diabetes often

More information

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012

Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012 Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012 In 2002, SETMA began a relationship with Joslin Diabetes

More information

230 S. Bemiston; Suite 900 Clayton, MO 63105 (314)727-5522 FAX (314)727-5568 www.mrctbenefitsplus.com www.mrctquote.com

230 S. Bemiston; Suite 900 Clayton, MO 63105 (314)727-5522 FAX (314)727-5568 www.mrctbenefitsplus.com www.mrctquote.com Life & Health Insurance Advisor MRCT Benefits Plus is a comprehensive employee benefits, wellness and Human Resources consulting firm offering a variety of financial services to businesses and individuals

More information

Patty Iron Cloud National Native American Youth Initiative Meeting June 20, 2011

Patty Iron Cloud National Native American Youth Initiative Meeting June 20, 2011 Patty Iron Cloud National Native American Youth Initiative Meeting June 20, 2011 Indian Health Service Overview by Yvette Roubideaux, M.D., M.P.H. Director, Indian Health Service (The Patty Iron Cloud

More information

Burden of Obesity, Diabetes and Heart Disease in New Hampshire, 2013 Update

Burden of Obesity, Diabetes and Heart Disease in New Hampshire, 2013 Update Burden of Obesity, Diabetes and Heart Disease in New Hampshire, 2013 Update Background Overweight and obesity have greatly increased among all age groups and regardless of income and education. Contributing

More information

Diabetes and SCI 2007

Diabetes and SCI 2007 Diabetes and SCI 2007 Long term spinal cord injury (SCI) and diabetes? Some research suggests the two go hand in hand with as many as 20 percent of spinal cord injured people having adult-onset diabetes.

More information

Biotherapeutic Medicines

Biotherapeutic Medicines International Federation of Pharmaceutical Manufacturers & Associations Biotherapeutic Medicines Grasping the New Generation of Treatments Biotherapeutic medicines are an integral and valuable part of

More information

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals

The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals The Geography of Markets for Technology: Evidence from Bio- Pharmaceuticals Michelle Gittelman Department of Business and Management Rutgers Business School Newark-New Brunswick, New Jersey The pharmaceutical

More information

AFFITECH and XOMA Sign Antibody Collaboration and Cross-License Agreement

AFFITECH and XOMA Sign Antibody Collaboration and Cross-License Agreement FOR IMMEDIATE RELEASE Ref 05AFF05 Contacts for Affitech: Contacts for XOMA Affitech (Norway): Investor Inquiries Dr. Martin Welschof Ellen M Martin Chief Executive Officer Kureczka/Martin Associates Phone:

More information

Pharmaceutical Report Royalty Purchasing Industry. Thomas R. Wells

Pharmaceutical Report Royalty Purchasing Industry. Thomas R. Wells Pharmaceutical Report Royalty Purchasing Industry Thomas R. Wells Table of Contents Industry Overview 2 How Transactions Work 2 Advantages & Disadvantages for Inventors and Investors 4 Major Investors

More information

Reducing Waste with an Efficient Medicare Prescription Drug Benefit

Reducing Waste with an Efficient Medicare Prescription Drug Benefit Issue Brief January 2013 Reducing Waste with an Efficient Medicare Prescription Drug Benefit BY DEAN BAKER* When Congress was debating the Medicare drug benefit in 2003, there were many who advocated that

More information

TABLE OF CONTENTS. 1. Introduction. 1.1. Dementia and Alzheimer Prevalence. 2. Global Alzheimer Market and Performance. 2.1.

TABLE OF CONTENTS. 1. Introduction. 1.1. Dementia and Alzheimer Prevalence. 2. Global Alzheimer Market and Performance. 2.1. 1 Disclaimer The research reports provided by AM Mindpower Solutions are for the personal information of the authorised recipient and is not for public distribution and should not be reproduced or redistributed

More information

2019 Healthcare That Works for All

2019 Healthcare That Works for All 2019 Healthcare That Works for All This paper is one of a series describing what a decade of successful change in healthcare could look like in 2019. Each paper focuses on one aspect of healthcare. To

More information

HEALTH CARE COSTS 11

HEALTH CARE COSTS 11 2 Health Care Costs Chronic health problems account for a substantial part of health care costs. Annually, three diseases, cardiovascular disease (including stroke), cancer, and diabetes, make up about

More information

Taking a statin to reduce the risk of coronary heart disease and stroke

Taking a statin to reduce the risk of coronary heart disease and stroke Patient decision aid Taking a statin to reduce the risk of coronary heart disease and stroke http://www.nice.org.uk/guidance/cg181/resources/cg181-lipid-modification-update-patient-decisionaid2 Published:

More information

A Letter from MabVax Therapeutics President and Chief Executive Officer

A Letter from MabVax Therapeutics President and Chief Executive Officer A Letter from MabVax Therapeutics President and Chief Executive Officer Dear Fellow Stockholder: You have invested in MabVax Therapeutics because you share our passion for finding new therapies for the

More information

Wasteful spending in the U.S. health care. Strategies for Changing Members Behavior to Reduce Unnecessary Health Care Costs

Wasteful spending in the U.S. health care. Strategies for Changing Members Behavior to Reduce Unnecessary Health Care Costs Strategies for Changing Members Behavior to Reduce Unnecessary Health Care Costs by Christopher J. Mathews Wasteful spending in the U.S. health care system costs an estimated $750 billion to $1.2 trillion

More information

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases

Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases Saving healthcare costs by implementing new genetic risk tests for early detection of cancer and prevention of cardiovascular diseases Jeff Gulcher, MD PhD Chief Scientific Officer and co-founder decode

More information

Driving Innovation in Licensing Through Competitive Intelligence and Big Data Analytics

Driving Innovation in Licensing Through Competitive Intelligence and Big Data Analytics Driving Innovation in Licensing Through Competitive Intelligence and Big Data Analytics John D Antonio Practice Leader, Licensing & Competitive Intelligence About Paragon We help increase asset value from

More information

In Pharma Cases, Injunctions Are In Public Interest

In Pharma Cases, Injunctions Are In Public Interest Portfolio Media. Inc. 648 Broadway, Suite 200 New York, NY 10012 www.law360.com Phone: +1 212 537 6331 Fax: +1 212 537 6371 customerservice@portfoliomedia.com In Pharma Cases, Injunctions Are In Public

More information

Consequences of the Bayh-Dole Act

Consequences of the Bayh-Dole Act Consequences of the Bayh-Dole Act 6.901 Final Paper Professor Robert Rhines December 12, 2005 David Levenson Levenson 1 Introduction The Bayh-Dole Act of 1980 is arguably one of the most influential pieces

More information

IDSC White Paper Series:

IDSC White Paper Series: 310 N. Main St., Suite 301 Chelsea, MI 48118. USA 734-433-9670 I N T E R N A T I O N A L D I S C O V E R Y S E R V I C E S & C O N S U L T I N G IDSC White Paper Series: Commercial Valuations and Due Diligence

More information

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute

A Texas Life Science Perspective. Thomas R. Kowalski President Texas Healthcare and Bioscience Institute A Texas Life Science Perspective Thomas R. Kowalski President Texas Healthcare and Bioscience Institute 1 What is THBI? The Texas Healthcare and Bioscience Institute (THBI) is a non-profit, public policy

More information

Third-Quarter 2015 Earnings Conference Call Executive Commentary Highlights. October 27, 2015

Third-Quarter 2015 Earnings Conference Call Executive Commentary Highlights. October 27, 2015 Third-Quarter 2015 Earnings Conference Call Executive Commentary Highlights October 27, 2015 Forward-Looking Statement of Merck & Co., Inc., Kenilworth, N.J., USA This presentation of Merck & Co., Inc.,

More information

Like John Fogerty said in one of his hit songs, I see a bad moon arising, How to Decrease Your Health Care Costs for Employees with Diabetes

Like John Fogerty said in one of his hit songs, I see a bad moon arising, How to Decrease Your Health Care Costs for Employees with Diabetes How to Decrease Your Health Care Costs for Employees with Diabetes Written by Tom Milam Like John Fogerty said in one of his hit songs, I see a bad moon arising, I see trouble on the way, the self-insured

More information

THE BIOTECH & PHARMACEUTICAL INDUSTRY

THE BIOTECH & PHARMACEUTICAL INDUSTRY THE BIOTECH & PHARMACEUTICAL INDUSTRY ESSENTIAL CAREERS INFORMATION CALUM LECKIE KATIE BISARO CAREERS CONSULTANTS What we will cover Sector overview Types of role Graduate recruitment trends and issues

More information

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD

CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD CLINICAL TRIALS SHOULD YOU PARTICIPATE? by Gwen L. Nichols, MD Gwen L. Nichols, M.D., is currently the Oncology Site Head of the Roche Translational Clinical Research Center at Hoffman- LaRoche. In this

More information

SPHERIX INCORPORATED (Exact name of registrant as specified in its charter)

SPHERIX INCORPORATED (Exact name of registrant as specified in its charter) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event

More information

Causes, incidence, and risk factors

Causes, incidence, and risk factors Causes, incidence, and risk factors Insulin is a hormone produced by the pancreas to control blood sugar. Diabetes can be caused by too little insulin, resistance to insulin, or both. To understand diabetes,

More information

Biomedical Business: Current Trends, Product Challenges and Future Outlook

Biomedical Business: Current Trends, Product Challenges and Future Outlook Biomedical Business: Current Trends, Product Challenges and Future Outlook Prepared and Presented by Audrey S. Erbes, Ph.D. Principal, Erbes & Associates Life Science Marketing and Business Development

More information

FROM MOLECULES TO MEDICINE: HOW ARE NEW DRUGS & THERAPIES DEVELOPED?

FROM MOLECULES TO MEDICINE: HOW ARE NEW DRUGS & THERAPIES DEVELOPED? FROM MOLECULES TO MEDICINE: HOW ARE NEW DRUGS & THERAPIES DEVELOPED? FROM MOLECULES TO MEDICINE: HOW ARE NEW DRUGS & THERAPIES DEVELOPED? Introduction This Global Genes Toolkit will provide you with an

More information

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care

TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY. Understanding the Complications That May Happen Without Proper Care TYPE 2 DIABETES IN THE AFRICAN AMERICAN COMMUNITY Understanding the Complications That May Happen Without Proper Care STAYING HEALTHY THE IMPORTANCE OF PROPER MANAGEMENT OF TYPE 2 DIABETES Diabetes is

More information

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry

Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Shifting paths of pharmaceutical innovation: Implications for the global pharmaceutical industry Tariq Sadat PhD Candidate School of Economics, Finance and Marketing, RMIT University, Australia Roslyn

More information

Flamel Technologies Provides Update on Corporate Progress

Flamel Technologies Provides Update on Corporate Progress Flamel Technologies Provides Update on Corporate Progress Clinical Programs Continue to Move Forward Outlines Full Year 2016 Revenue Guidance Lyon, France January 8, 2016 - Flamel Technologies (NASDAQ:

More information

Health Passport. Your Journey to Wellness. Health Fair ID#

Health Passport. Your Journey to Wellness. Health Fair ID# Health Passport Your Journey to Wellness Health Fair ID# Body Mass Index What is BMI? Your body mass index, or BMI, shows the amount of fat in your body. BMI is calculated using height, weight, and waist

More information

What is diabetes? Diabetes is a condition which occurs as a result of problems with the production and supply of insulin in the body.

What is diabetes? Diabetes is a condition which occurs as a result of problems with the production and supply of insulin in the body. What is diabetes? Diabetes is a condition which occurs as a result of problems with the production and supply of insulin in the body. Most of the food we eat is turned into glucose, a form of sugar. We

More information

The UnitedHealthcare Diabetes Health Plan Better information. Better decisions. Better results. Agenda

The UnitedHealthcare Diabetes Health Plan Better information. Better decisions. Better results. Agenda The UnitedHealthcare Better information. Better decisions. Better results. 1 Agenda Market Health Trends- declining health status and increase disease prevalence Optimal Decisions and Opportunity for Improvement

More information

Press Release. iphex 2013 to showcase on Indian pharma exports; R & D capabilities

Press Release. iphex 2013 to showcase on Indian pharma exports; R & D capabilities Press Release iphex 2013 to showcase on Indian pharma exports; R & D capabilities Pharmexcil s iphex 2013 for global showcasing of Indian Pharma products Over 400 international buyers and regulators expected

More information

REAL-LIFE BIOINSURANCE

REAL-LIFE BIOINSURANCE REAL-LIFE BIOINSURANCE WELCOME TO ACCELLERATE AN INVESTMENT LIKE NO OTHER Your clients trust your skills and expertise to guide them to the best products to plan for a secure future. This is exactly why

More information

Understanding Obesity

Understanding Obesity Your Guide to Understanding Obesity As your partner in health for your life s journey, we want you to be as informed and confident as possible regarding the disease or medical issue you may be facing.

More information

Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs

Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs T H E F A C T S A B O U T Upstate New York adults with diagnosed type 1 and type 2 diabetes and estimated treatment costs Upstate New York Adults with diagnosed diabetes: 2003: 295,399 2008: 377,280 diagnosed

More information

Photocure ASA. Exclusive global Licence Agreement for Lumacan with Salix Pharmaceuticals, Inc. 20 October 2010 Kjetil Hestdal, President & CEO

Photocure ASA. Exclusive global Licence Agreement for Lumacan with Salix Pharmaceuticals, Inc. 20 October 2010 Kjetil Hestdal, President & CEO Brilliance in photodynamic technology TM Photocure ASA Exclusive global Licence Agreement for Lumacan with Salix Pharmaceuticals, Inc. 20 October 2010 Kjetil Hestdal, President & CEO Agreement with Salix

More information

Narrowing the Gap. Clinical Development and Regulatory Pathways for Medical Technologies for Neglected Diseases. Tom Bollyky

Narrowing the Gap. Clinical Development and Regulatory Pathways for Medical Technologies for Neglected Diseases. Tom Bollyky Narrowing the Gap Clinical Development and Regulatory Pathways for Medical Technologies for Neglected Diseases Tom Bollyky Stanford Law School Drug Development and International Access Conference April

More information